Skip to main content
OpenTrials

Clinical trial condition

Primary Peritoneal Cancer

Explore clinical trials studying Primary Peritoneal Cancer. Study availability and eligibility vary by location and protocol.

91 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Primary Peritoneal Cancer trial results

Completed

RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

NCT06173037

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
View all 30 locations
View Trial Details
Completed

Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients

NCT04227522

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +23 more
Locations
  • Universitätsklinikum Aachen Aachen, Germany
  • ANregiomed Frauenklinik Ansbach Ansbach, Germany
  • Helios Klinikum Berlin-Buch Berlin, Germany
  • Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum Berlin, Germany
View all 17 locations
View Trial Details
Completed

A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03635489

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Beijing Obstetrics and Gynecology Hospital, Capital Medical University Beijing, China
  • the First Hospital of Jilin University Changchun, China
  • Jilin Cancer Hospital Changchun, China
  • Xiangya Hospital Central South University Changsha, China
View all 16 locations
View Trial Details
Completed

Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer

NCT02480374

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • University of Alabama Birmingham Cancer Center Birmingham, Alabama, United States
  • Washington Univ. in St. Louis/Barnes Jewish Hospital St Louis, Missouri, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Medical College of Wisconsin/Froedtert Hospital Milwaukee, Wisconsin, United States
View Trial Details
Completed

Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer

NCT03759600

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki, Aomori, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • The Jikei University Kashiwa Hospital Kashiwa, Chiba, Japan
View all 33 locations
View Trial Details
Completed

Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer

NCT02606305

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • City of Hope Reno, Nevada, United States
View Trial Details

Related conditions